Stock Insights: Complete Genomics, Mentor Graphics May 29th

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Complete Genomics, Inc. (NASDAQ:GNOM): After Complete Genomics (NASDAQ:GNOM) and a number of other small-cap genomic stocks surged over the past two days, Mizuho sees no news to justify the rallies. The firm maintains Buy rating on Complete Genomic (NASDAQ:GNOM) and Illumina (NASDAQ:ILMN), and a Neutral rating on Life Technologies (NASDAQ:LIFE)

Mentor Graphics Corp. (NASDAQ:MENT): DA Davidson raised Mentor estimates based on increased operating leverage following the Q1 report. The firm reiterates its Buy rating given management’s focus on cost controls, growth opportunity, and favorable risk/reward.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business